Publisher's Synopsis
Surgeons and cardiologists today are confronted with an ever–increasing number of patients with end–stage heart failure and a concurrent decreasing number of donor hearts. For a significant number of cases, cardiac bioassist represents a practical alternative. And for the foreseeable future, Cardiac